REATA PHARMACEUTICALS INC Financing Cash Flow
REATA PHARMACEUTICALS INC reported Financing Cash Flow of $89.86 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-08-08
- REATA PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $76.78M, a 14091.68% increase year-over-year.
- REATA PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $13.08M, a 6643.30% increase year-over-year.
- REATA PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $314.00K, a 83.63% increase year-over-year.
- REATA PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $436.00K, a 29.38% increase year-over-year.
- REATA PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2022 was $1.49M, a 83.75% decline from fiscal 2021.
- REATA PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2021 was $9.14M, a 98.08% decline from fiscal 2020.
- REATA PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2020 was $477.09M, a 17.79% decline from fiscal 2019.
- REATA PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2019 was $580.36M, a 98.43% increase from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-06-30 | $76.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $89.86M 10-Q · filed 2023-08-08 | $90.17M derived: sum of 3 quarters · filed 2023-08-08 | $90.61M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $13.08M 10-Q · filed 2023-05-10 | $13.40M derived: sum of 2 quarters · filed 2023-05-10 | $13.83M derived: sum of 3 quarters · filed 2023-05-10 | $14.37M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $750.00K derived: sum of 2 quarters · filed 2023-02-24 | $1.29M derived: sum of 3 quarters · filed 2023-08-08 | $1.49M 10-K · filed 2023-02-24 |
| 2022-09-30 | $436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $977.00K derived: sum of 2 quarters · filed 2023-08-08 | $1.17M 10-Q · filed 2022-11-08 | $1.34M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $541.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $735.00K 10-Q · filed 2023-08-08 | $906.00K derived: sum of 3 quarters · filed 2023-08-08 | $1.24M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $194.00K 10-Q · filed 2023-05-10 | $365.00K derived: sum of 2 quarters · filed 2023-05-10 | $702.00K derived: sum of 3 quarters · filed 2023-05-10 | $4.65M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $508.00K derived: sum of 2 quarters · filed 2023-02-24 | $4.46M derived: sum of 3 quarters · filed 2023-02-24 | $9.14M 10-K · filed 2023-02-24 |
| 2021-09-30 | $337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.29M derived: sum of 2 quarters · filed 2022-11-08 | $8.97M 10-Q · filed 2022-11-08 | $294.38M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $8.63M 10-Q · filed 2022-08-08 | $294.05M derived: sum of 3 quarters · filed 2023-02-24 | $302.14M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $4.68M 10-Q · filed 2022-05-10 | $290.09M derived: sum of 2 quarters · filed 2023-02-24 | $298.19M derived: sum of 3 quarters · filed 2023-02-24 | $480.35M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $285.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $293.51M derived: sum of 2 quarters · filed 2023-02-24 | $475.67M derived: sum of 3 quarters · filed 2023-02-24 | $477.09M 10-K · filed 2023-02-24 |
| 2020-09-30 | $8.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $190.26M derived: sum of 2 quarters · filed 2021-11-08 | $191.68M 10-Q · filed 2021-11-08 | $765.48M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $182.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $183.59M 10-Q · filed 2021-08-09 | $757.39M derived: sum of 3 quarters · filed 2022-02-28 | $757.75M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.42M 10-Q · filed 2021-05-06 | $575.23M derived: sum of 2 quarters · filed 2022-02-28 | $575.59M derived: sum of 3 quarters · filed 2022-02-28 | $576.62M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $573.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $574.17M derived: sum of 2 quarters · filed 2022-02-28 | $575.20M derived: sum of 3 quarters · filed 2022-02-28 | $580.36M 10-K · filed 2022-02-28 |
| 2019-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.40M derived: sum of 2 quarters · filed 2020-11-09 | $6.55M 10-Q · filed 2020-11-09 | $6.97M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $6.19M 10-Q · filed 2020-08-10 | $6.60M derived: sum of 3 quarters · filed 2021-03-01 | $240.07M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $5.16M 10-Q · filed 2020-05-11 | $5.57M derived: sum of 2 quarters · filed 2021-03-01 | $239.04M derived: sum of 3 quarters · filed 2021-03-01 | $297.30M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $233.88M derived: sum of 2 quarters · filed 2021-03-01 | $292.14M derived: sum of 3 quarters · filed 2021-03-01 | $292.47M 10-K · filed 2021-03-01 |
| 2018-09-30 | $233.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $291.73M derived: sum of 2 quarters · filed 2019-11-12 | $292.06M 10-Q · filed 2019-11-12 | $292.11M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $58.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $58.59M 10-Q · filed 2019-08-08 | $58.64M derived: sum of 3 quarters · filed 2020-02-19 | $167.25M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $329.00K 10-Q · filed 2019-05-09 | $377.00K derived: sum of 2 quarters · filed 2020-02-19 | $108.98M derived: sum of 3 quarters · filed 2020-02-19 | |
| 2017-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $108.65M derived: sum of 2 quarters · filed 2020-02-19 | $128.65M 10-K · filed 2020-02-19 | |
| 2017-09-30 | $108.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $128.60M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $19.99M 10-Q · filed 2018-08-08 | |||
| 2016-12-31 | $62.32M 10-K · filed 2019-02-28 |